{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:36:03Z","timestamp":1787506563773,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.brainres.2024.149246","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T04:52:04Z","timestamp":1726635124000},"page":"149246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Ameliorative effect of diclofenac in rotenone corneal kindling model of drug-resistant epilepsy: Edge of dual COX and KMO inhibition"],"prefix":"10.1016","volume":"1846","author":[{"family":"Samriti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.K.","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2024.149246_b0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2010.09.009","article-title":"Targeting cyclooxygenases-1 and-2 in neuroinflammation: therapeutic implications","volume":"93","author":"A\u00efd","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.brainres.2024.149246_b0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1358\/mf.2009.31.7.1393610","article-title":"Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice","volume":"31","author":"Akula","year":"2009","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"17","key":"10.1016\/j.brainres.2024.149246_b0020","article-title":"Electrophysiologic and anti-inflammatorial effects of cyclooxygenase inhibition in epileptiform activity","volume":"11","author":"Akunal T\u00fcrel","year":"2023","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.brainres.2024.149246_b0025","first-page":"118","article-title":"Effects of non-steroidal anti-inflammatory drugs on anticonvulsant activity of diazepam in mice","volume":"1","author":"Almaghour","year":"2014","journal-title":"Pharm. Pharmacol. Int. J."},{"key":"10.1016\/j.brainres.2024.149246_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/1178646919834551","article-title":"Simultaneous determination of kynurenine and kynurenic acid by high-performance liquid chromatography photoirradiation system using a mobile phase containing 18-crown-6","volume":"12","author":"Atsumi","year":"2019","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.brainres.2024.149246_b0035","doi-asserted-by":"crossref","DOI":"10.4137\/IJTR.S6225","article-title":"Rapid isocratic liquid chromatographic separation and quantification of tryptophan and six kynurenine metabolites in biological samples with ultraviolet and fluorimetric detection","volume":"3","author":"Badawy","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.brainres.2024.149246_b0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/brainsci11050663","article-title":"Mechanisms of drug resistance in the pathogenesis of epilepsy: role of neuroinflammation","volume":"11","author":"Bazhanova","year":"2021","journal-title":"Lit. Rev. Brain Sci."},{"key":"10.1016\/j.brainres.2024.149246_b0045","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.stem.2023.08.013","article-title":"Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy","volume":"30","author":"Bershteyn","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.brainres.2024.149246_b0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood.V21.5.573.573","article-title":"Erythrocyte glutathione reductase","volume":"21","author":"Beutler","year":"1963","journal-title":"Blood"},{"key":"10.1016\/j.brainres.2024.149246_b0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainres.2024.149246_b0060","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/epi4.12590","article-title":"Factors not considered in the study of drug-resistant epilepsy: drug-resistant epilepsy: assessment of neuroinflammation","volume":"7","author":"Campos-Bedolla","year":"2022","journal-title":"Epilepsia Open."},{"key":"10.1016\/j.brainres.2024.149246_b0065","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/ijms14011455","article-title":"Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models","volume":"14","author":"Cardenas-Rodriguez","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2024.149246_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.138251","article-title":"Pesticides at brain borders: impact on the blood-brain barrier, neuroinflammation, and neurological risk trajectories","volume":"324","author":"Cresto","year":"2023","journal-title":"Chemosphere"},{"issue":"9","key":"10.1016\/j.brainres.2024.149246_b0075","article-title":"Nociceptive improvements and kynurenine pathway alterations with diclofenac treatment in a rat model of neuropathic pain created by partial sciatic nerve ligation","volume":"27","author":"Debbag","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2024.149246_b0080","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1111\/bph.15534","article-title":"Altered hippocampal kynurenine pathway metabolism contributes to hyperexcitability in human mesial temporal lobe epilepsy\u2013hippocampal sclerosis","volume":"178","author":"Dey","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149246_b0085","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s11064-020-03054-7","article-title":"Effects of diclofenac versus meloxicam in pentylenetetrazol-kindled mice","volume":"45","author":"Elgarhi","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2024.149246_b0090","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s11064-022-03838-z","article-title":"Effects of diclofenac sodium on seizure activity in rats with pentylenetetrazole-induced convulsions","volume":"48","author":"Erdogan","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2024.149246_b0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mito.2011.04.004","article-title":"Mitochondrial dysfunction in epilepsy","volume":"12","author":"Folbergrov\u00e1","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.brainres.2024.149246_b0100","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","article-title":"Diclofenac: an update on its mechanism of action and safety profile","volume":"26","author":"Gan","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.brainres.2024.149246_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.04.019","article-title":"Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation","volume":"94","author":"Garrison","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainres.2024.149246_b0110","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.nbd.2012.03.010","article-title":"A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain","volume":"46","author":"Ghosh","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2024.149246_b0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/biomedicines9050470","article-title":"Pharmacological and therapeutic approaches in the treatment of epilepsy","volume":"9","author":"Ghosh","year":"2021","journal-title":"Biomedicines."},{"key":"10.1016\/j.brainres.2024.149246_b0125","article-title":"Mechanistic investigations of the mitochondrial complex I inhibitor rotenone in the context of pharmacological and safety evaluation","volume":"1\u201313","author":"Heinz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2024.149246_b0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"The Lancet Neurol."},{"key":"10.1016\/j.brainres.2024.149246_b0135","article-title":"IDO and kynurenine metabolites in peripheral and CNS disorders","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2024.149246_b0140","doi-asserted-by":"crossref","first-page":"858","DOI":"10.14336\/AD.2022.0916","article-title":"Tryptophan metabolism in central nervous system diseases: pathophysiology and potential therapeutic strategies","volume":"14","author":"Huang","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.brainres.2024.149246_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107246","article-title":"Adjunct antiseizure effect of clotrimazole in a rotenone corneal kindling mouse model of mitochondrial drug-resistant epilepsy","volume":"198","author":"Kaur","year":"2023","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.brainres.2024.149246_b0155","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s11064-016-2001-2","article-title":"Protective effect of nerolidol against pentylenetetrazol-induced kindling, oxidative stress and associated behavioral comorbidities in mice","volume":"41","author":"Kaur","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2024.149246_b0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ame2.12131","article-title":"Pharmacokinetic, pharmacodynamic, and neurochemical investigations of lamotrigine-pentylenetetrazole kindled mice to ascertain it as a reliable model for clinical drug-resistant epilepsy","volume":"3","author":"Kumar","year":"2020","journal-title":"Animal Models Exp. Med."},{"key":"10.1016\/j.brainres.2024.149246_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105754","article-title":"Bioinformatics guided rotenone adjuvant kindling in mice as a new animal model of drug-resistant epilepsy","volume":"147","author":"Kumar","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.brainres.2024.149246_b0170","doi-asserted-by":"crossref","first-page":"IJTR-S8158","DOI":"10.4137\/IJTR.S8158","article-title":"Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms","volume":"5","author":"La Cruz","year":"2012","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.brainres.2024.149246_b0175","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.7150\/ijbs.83392","article-title":"Inhibition of KMO ameliorates myocardial ischemia injury via maintaining mitochondrial fusion and fission balance","volume":"19","author":"Lai","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.brainres.2024.149246_b0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1528-1157.1981.tb04108.x","article-title":"Kynurenines and seizures","volume":"22","author":"Lapin","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainres.2024.149246_b0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-022-02613-9","article-title":"Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer\u2019s disease","volume":"19","author":"Li","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.brainres.2024.149246_b0195","first-page":"2101","article-title":"Oxidative stress in pharmacoresistant epilepsy","volume":"33","author":"Lorigados","year":"2016","journal-title":"Biotecnolog\u00eda Aplicada"},{"key":"10.1016\/j.brainres.2024.149246_b0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(84)90243-7","article-title":"Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy","volume":"99","author":"Loscher","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149246_b0205","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1007\/s10072-021-05551-1","article-title":"A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"42","author":"Mani","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.brainres.2024.149246_b0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.brainres.2024.149246_b0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12974-019-1592-3","article-title":"Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management","volume":"16","author":"Rawat","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2024.149246_b0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.freeradbiomed.2013.02.002","article-title":"Mitochondrial involvement and oxidative stress in temporal lobe epilepsy","volume":"62","author":"Rowley","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2024.149246_b0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/antiox11020315","article-title":"Cellular localization of kynurenine 3-monooxygenase in the brain: challenging the dogma","volume":"11","author":"Sathyasaikumar","year":"2022","journal-title":"Antioxidants."},{"key":"10.1016\/j.brainres.2024.149246_b0230","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1007\/s00213-022-06263-w","article-title":"Acute administration of ibuprofen increases serum concentration of the neuroprotective kynurenine pathway metabolite, kynurenic acid: a pilot randomized, placebo-controlled, crossover study","volume":"239","author":"Savitz","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2024.149246_b0235","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1476-5381.2010.00765.x","article-title":"Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy","volume":"160","author":"Schlichtiger","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149246_b0240","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00702-004-0231-y","article-title":"Prostaglandin-mediated control of rat brain kynurenic acid synthesis\u2013opposite actions by COX-1 and COX-2 isoforms","volume":"112","author":"Schwieler","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2024.149246_b0245","doi-asserted-by":"crossref","first-page":"14850","DOI":"10.1523\/JNEUROSCI.3922-11.2011","article-title":"Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus","volume":"31","author":"Serrano","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2024.149246_b0250","article-title":"Neurobiology and therapeutic potential of cyclooxygenase-2 (COX-2) inhibitors for inflammation in neuropsychiatric disorders","volume":"10","author":"Sethi","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.brainres.2024.149246_b0255","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1021\/acsomega.7b02091","article-title":"Diclofenac identified as a kynurenine 3-monooxygenase binder and inhibitor by molecular similarity techniques","volume":"3","author":"Shave","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.brainres.2024.149246_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2015.04.007","article-title":"Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity","volume":"49","author":"Singh","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainres.2024.149246_b0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bcpt.12238","article-title":"Characterization of a lamotrigine-resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanisms","volume":"115","author":"Singh","year":"2014","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"key":"10.1016\/j.brainres.2024.149246_b0270","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.18203\/2319-2003.ijbcp20204098","article-title":"\u201cWe are antidepressant also\u201d: aspirin and diclofenac sodium","volume":"9","author":"Sumanth","year":"2020","journal-title":"Int. J. Basic Clin. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149246_b0275","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2174\/092986712800167365","article-title":"Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects","volume":"19","author":"Szal\u00e1rdy","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.brainres.2024.149246_b0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/bs13020097","article-title":"Epilepsy: a multifaced Spectrum disorder","volume":"13","author":"Vetri","year":"2023","journal-title":"Behav. Sci."},{"key":"10.1016\/j.brainres.2024.149246_b0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2016.08.020","article-title":"Effect of diclofenac sodium on seizures and inflammatory profile induced by kindling seizure model","volume":"127","author":"Vieira","year":"2016","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.brainres.2024.149246_b0290","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1038\/s41598-024-57224-6","article-title":"Determination of oxidative stress level and some antioxidant activities in refractory epilepsy patients","volume":"14","author":"Yilgor","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2024.149246_b0295","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s11064-013-1055-7","article-title":"Rotenone could activate microglia through NF\u03baB associated pathway","volume":"38","author":"Yuan","year":"2013","journal-title":"Neurochem. Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324005006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324005006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T20:09:10Z","timestamp":1753301350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899324005006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":55,"alternative-id":["S0006899324005006"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149246","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ameliorative effect of diclofenac in rotenone corneal kindling model of drug-resistant epilepsy: Edge of dual COX and KMO inhibition","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149246"}}